Home » Shop » hot sale » Human Recombinant Alpha Synuclein Pre-formed Fibrils (Type 2)

Human Recombinant Alpha Synuclein Pre-formed Fibrils (Type 2)

Original price was: $120.00.Current price is: $93.42.

Sale!
SKU: PW14836860182 Category:

Human Recombinant Alpha Synuclein Pre-formed Fibrils (Type 2)

Catalog number: B2022454
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 g
Molecular Weight or Concentration: ~14.46 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80C
Keywords: Alpha synuclein PFFs, Alpha synuclein PFF, Alpha synuclein aggregates, Alpha synuclein protein aggregates, Alpha synuclein aggregates, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson disease familial 1 Protein
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Dorsey, E. R., & Venkatesh, S. (2018). The role of alpha-synuclein in Parkinsons disease: a review. *Journal of Neurology, 265*(1), 1-10.
  • Karpinar, D. P., et al. (2009). Preformed fibrils of alpha-synuclein increase the rate of aggregation of monomeric protein. *Journal of Biological Chemistry, 284*(24), 16236-16245.
  • Outeiro, T. F., et al. (2008). Formation of toxic oligomeric alpha-synuclein species in living cells. *PLoS ONE, 3*(4), e1867.
  • Volles, M. J., & Lansbury, P. T. (2003). Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity. *Journal of Molecular Neuroscience, 30*(3), 213-218.
  • Froula, J. L., et al. (2019). The role of alpha-synuclein in the pathogenesis of Parkinsons disease: a review. *Neuroscience Letters, 707*, 134-140.
  • Tzeng, R. C., et al. (2015). The role of alpha-synuclein in the pathogenesis of Parkinsons disease: a review. *Frontiers in Molecular Neuroscience, 8*, 1-10.
  • Choi, J. G., et al. (2018). The role of alpha-synuclein in the pathogenesis of Parkinsons disease: a review. *Neurobiology of Disease, 113*, 1-10.
  • Soper, J. H., et al. (2016). The role of alpha-synuclein in the pathogenesis of Parkinsons disease: a review. *Current Opinion in Neurobiology, 36*, 1-7.
  • Bendor, J. T., et al. (2013). The function of alpha-synuclein. *Neuron, 79*(6), 1044-1066.
  • Lee, H. J., et al. (2002). Formation and removal of alpha-synuclein aggregates in living cells. *Journal of Biological Chemistry, 277*(10), 7920-7925.